ALFA Finder| Revenue growth | GWP up 26% ex-1/n to ₹5,004 Cr; retail 37%, reported 47%. |
|---|---|
| Margins | CISR improved 365 bps to 99.5%; expense ratio down 78 bps. |
| Demand visibility | October retail growth in 30s; GST tailwind; expects volume steer from reforms. |
| Management confidence | Confident but defensive on claims criticism; dismissed broker feedback as anecdotal. |
Growth
GWP ex-1/n up 26% to ₹5,004 Cr; retail up 37%. Reported retail growth of 47% includes the 1/n benefit.
Outlook
No numeric growth guidance; ROE target mid-to-high teens; October retail growth 'in the 30s'; yield 7.4-7.5% sustainable.
Risks
Solvency 2.03x and falling; draft commission cuts may raise capital needs; broker claim-payment complaints dismissed as anecdotal.
Last quarter's promises, checked
Delivered
- Guided Q1 expense ratio +90bps to normalise post-Q3 → H1 expense ratio down 78bps (= BEAT)
Partly delivered
- Guided EoM stabilising at 32-33% → H1 expense ratio down 78bps, level undisclosed (= PARTIAL)
- Guided no H2 loss-ratio deterioration → H1 CISR 99.5% vs Q1 100.2%; H2 unreported (= PARTIAL)
Missed
- Guided retail 8-10pp above market → Q1 like-to-like 35.5% vs industry 31.6% (= MISS)
Earnings Call Transcript filed with BSE, NSE: NIVABUPA. Summary written with AI assistance from the document.
Niva Bupa Health Insurance Company Ltd: key numbers
- Share price
- ₹78.55
- Market cap
- ₹14,537 Cr
- Revenue (annual)
- ₹6,695 Cr
- Net profit (annual)
- ₹130.8 Cr
- P/E (TTM)
- 27.4×Sector 20.8×
- Promoter holding
- 55.29%-0.01% QoQ
- FII holding
- 12.95%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Niva Bupa Health Insurance Company Ltd
All →Niva Bupa Health Insurance Company Results Update
Niva Bupa reported Q2 FY27 PAT of ₹136 crore, up 124%, and GWP of ₹2,484 crore, up 35%. The release highlights strong Retail Health growth and an improved solvency ratio.
Niva Bupa Health Insurance Company Board Meeting Outcome
Niva Bupa Health Insurance Company's Board approved amendments and the consolidation of its PIT policies. The updated policy integrates UPSI fair disclosure and leak inquiry procedures into a single framework.
Niva Bupa Health Insurance Company Investor Presentation: Key Takeaways
H1 FY27 GWP ₹4,634 Cr (+33.4% y-o-y, 1/n basis); PAT ₹273.4 Cr, more than doubled; CISR improved to 99.5% from 103.1%; retail health share 11.0%.
Niva Bupa Health Insurance Company Other Announcement
Niva Bupa Health Insurance's Board approved the amendment and consolidation of its UPSI Fair Disclosure and Leak Inquiry policies. The integrated policy streamlines operational compliance under SEBI PIT Regulations.
Niva Bupa Health Insurance Company Q2 FY27 Results: Net Profit ₹135.6 Cr, Up 124.1% YoY
Niva Bupa Health Insurance Company Ltd reported revenue from operations of ₹2,572 Cr (+25.5% YoY) and net profit of ₹135.6 Cr (+124.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹135.6 Cr · +124.1% YoY
Niva Bupa Health Insurance Company Employee Stock Options
Niva Bupa allotted 9,89,450 equity shares to employees on exercise of ESOP options under its 2020 and 2024 schemes. Paid-up capital rose to Rs. 18,50,63,41,530.